Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (4)
Scientific Reports (4)
Cellular & Molecular Immunology (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (8)
Amendments and Corrections (2)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cancer
Gastroenterology
Immunology
Medical research
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–10 of 10 results

Advanced filters: Author: Hyung-Don Kim Clear advanced filters

Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer

Keun-Wook Lee
Dae Young Zang
Hark Kyun Kim
Amendments and Corrections11 Nov 2025
British Journal of Cancer

Volume: 133, P: 1928
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial

In the phase 2 RENOBATE trial, the combination of regorafenib and nivolumab as first-line treatment for unresectable hepatocellular carcinoma exhibited a safe profile and met the primary endpoint with a 31% overall response rate.

Hyung-Don Kim
Seyoung Jung
Changhoon Yoo
ResearchOpen Access19 Feb 2024
Nature Medicine

Volume: 30, P: 699-707
Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer

Keun-Wook Lee
Da Young Zang
Hark Kyun Kim
Amendments and Corrections20 Jun 2025
British Journal of Cancer

Volume: 133, P: 274
Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment

Hyung-Don Kim
Sun Young Kim
Tae Won Kim
ResearchOpen Access31 Jan 2022
Scientific Reports

Volume: 12, P: 1-10
Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer

Keun-Wook Lee
Dae Young Zang
Hark Kyun Kim
Research21 May 2025
British Journal of Cancer

Volume: 133, P: 208-215
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer

Eugene Choi
Jinho Shin
Young Soo Park
ResearchOpen Access31 Jul 2024
Scientific Reports

Volume: 14, P: 1-9
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer

Hyung-Don Kim
Eugene Choi
Young Soo Park
ResearchOpen Access16 Nov 2023
Scientific Reports

Volume: 13, P: 1-8
A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours

Hyung-Don Kim
Changhoon Yoo
Yoon-Koo Kang
Research13 May 2023
British Journal of Cancer

Volume: 129, P: 275-282
Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients

Seung-Myoung Son
Chang Gok Woo
Hye Sook Han
ResearchOpen Access31 Aug 2020
Scientific Reports

Volume: 10, P: 1-12
PD-1 blockade-unresponsive human tumor-infiltrating CD8⁺ T cells are marked by loss of CD28 expression and rescued by IL-15

Kyung Hwan Kim
Hong Kwan Kim
Eui-Cheol Shin
Research24 Apr 2020
Cellular & Molecular Immunology

Volume: 18, P: 385-397